ASX - By Stock
|
CHM |
Re:
Ann: Resignation of CEO and Managing Director
|
|
FredQuell
|
59 |
13K |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
59
|
13K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
FredQuell
|
13K |
6.3M |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Resignation of CEO and Managing Director
|
|
FredQuell
|
59 |
13K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
59
|
13K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
FredQuell
|
13K |
6.3M |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
FredQuell
|
216 |
66K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
216
|
66K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
FredQuell
|
23K |
11M |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
23K
|
11M
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notification of cessation of securities - CHM
|
|
FredQuell
|
1 |
706 |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1
|
706
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Clinical milestones for 2024 & 2023 successes highlighted
|
|
FredQuell
|
26 |
9.1K |
3 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
26
|
9.1K
|
3
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
2 |
15/03/24 |
15/03/24 |
Charts
|
31K
|
15M
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
1 |
23/02/24 |
23/02/24 |
Charts
|
31K
|
15M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
2 |
21/02/24 |
21/02/24 |
Charts
|
31K
|
15M
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
36 |
07/02/24 |
07/02/24 |
Charts
|
31K
|
15M
|
36
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
FredQuell
|
77 |
37K |
3 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
77
|
37K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
FredQuell
|
177 |
78K |
3 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
177
|
78K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
FredQuell
|
177 |
78K |
4 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
177
|
78K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
FredQuell
|
177 |
78K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
177
|
78K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
FredQuell
|
177 |
78K |
6 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
177
|
78K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
FredQuell
|
177 |
78K |
5 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
177
|
78K
|
5
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
31 |
15/01/24 |
15/01/24 |
Charts
|
31K
|
15M
|
31
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial
|
|
FredQuell
|
242 |
109K |
5 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
242
|
109K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
FredQuell
|
228 |
93K |
1 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
93K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
FredQuell
|
23K |
11M |
5 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
23K
|
11M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
FredQuell
|
23K |
11M |
27 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
23K
|
11M
|
27
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
FredQuell
|
70 |
20K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
FredQuell
|
70 |
20K |
3 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: FDA clearance of IND for CHM 2101
|
|
FredQuell
|
70 |
20K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
20K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
FredQuell
|
23K |
11M |
0 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
23K
|
11M
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Dosing completion in Phase 1A brain cancer clinical trial
|
|
FredQuell
|
34 |
10K |
2 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
34
|
10K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Dosing completion in Phase 1A brain cancer clinical trial
|
|
FredQuell
|
34 |
10K |
5 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
34
|
10K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Resignation of Director
|
|
FredQuell
|
4 |
1.8K |
0 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
4
|
1.8K
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
2 |
27/07/23 |
27/07/23 |
Charts
|
31K
|
15M
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
2 |
27/07/23 |
27/07/23 |
Charts
|
31K
|
15M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Corporate Presentation
|
|
FredQuell
|
246 |
113K |
1 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
246
|
113K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Corporate Presentation
|
|
FredQuell
|
246 |
113K |
2 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
246
|
113K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Oncolytic Virotherapy CF33 Patent Allowed in the US
|
|
FredQuell
|
103 |
48K |
1 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
103
|
48K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Appoints Dr Weitzman Interim Chief Medical Officer
|
|
FredQuell
|
110 |
42K |
4 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
110
|
42K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Appoints Dr Weitzman Interim Chief Medical Officer
|
|
FredQuell
|
110 |
42K |
2 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
110
|
42K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Appoints Dr Weitzman Interim Chief Medical Officer
|
|
FredQuell
|
110 |
42K |
2 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
110
|
42K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Appoints Dr Weitzman Interim Chief Medical Officer
|
|
FredQuell
|
110 |
42K |
5 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
110
|
42K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Board Changes Director
|
|
FredQuell
|
21 |
8.6K |
0 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
21
|
8.6K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Board Changes Director
|
|
FredQuell
|
21 |
8.6K |
1 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
21
|
8.6K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
IMU Target $2.00 - Not Ramping !!!
|
|
FredQuell
|
288 |
141K |
17 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
288
|
141K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene doses first combination patient in PD1-Vaxx trial
|
|
FredQuell
|
115 |
58K |
17 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
115
|
58K
|
17
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
2 |
31/05/23 |
31/05/23 |
Charts
|
31K
|
15M
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
FredQuell
|
691 |
273K |
5 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
691
|
273K
|
5
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Analysts Reports (Imugene)
|
|
FredQuell
|
338 |
195K |
3 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
338
|
195K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
valuation thoughts
|
|
FredQuell
|
380 |
174K |
5 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
380
|
174K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: BOARD & MANAGEMENT COMMIT TO $1M PLACEMENT AND PROPOSED SPP
|
|
FredQuell
|
20 |
7.0K |
3 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
20
|
7.0K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
FredQuell
|
23K |
11M |
6 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
23K
|
11M
|
6
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
FredQuell
|
31K |
15M |
4 |
05/12/22 |
05/12/22 |
Charts
|
31K
|
15M
|
4
|
|